Changyu Shan

732 total citations
15 papers, 508 citations indexed

About

Changyu Shan is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Changyu Shan has authored 15 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Changyu Shan's work include Radiopharmaceutical Chemistry and Applications (3 papers), Peptidase Inhibition and Analysis (3 papers) and Autophagy in Disease and Therapy (2 papers). Changyu Shan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Peptidase Inhibition and Analysis (3 papers) and Autophagy in Disease and Therapy (2 papers). Changyu Shan collaborates with scholars based in China, United States and Chile. Changyu Shan's co-authors include Qin Ouyang, Ying‐Chun Chen, Chunling Guo, Hongwei Li, Xiuming Yang, Ning Gao, Qi Cheng, Jinwei Zhu, Guobing� Li and Qiong Chen and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Molecular Cancer.

In The Last Decade

Changyu Shan

14 papers receiving 504 citations

Peers

Countries citing papers authored by Changyu Shan

Since Specialization

Citations

This map shows the geographic impact of Changyu Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyu Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyu Shan more than expected).

Fields of papers citing papers by Changyu Shan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changyu Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyu Shan. The network helps show where Changyu Shan may publish in the future.

Co-authorship network of co-authors of Changyu Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Changyu Shan. A scholar is included among the top collaborators of Changyu Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changyu Shan. Changyu Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Preparation and evaluation of a novel albumin-binding heterodimer therapeutic radiopharmaceutical with remarkable tumor accumulation and retention 2025 ·European Journal of Medicinal Chemistry ·(unknown), Changyu Shan, (unknown), Mengyan Hu, Chunxia Qin, Dexing Zeng, (unknown), (unknown), Yongkang Gai	2
2	Design, Synthesis, and Evaluation of OncoFAP Derivatives with the Albumin Binder as Novel Antitumor Radiopharmaceuticals 2025 ·Chemical & Biomedical Imaging ·(unknown), (unknown), (unknown), Changyu Shan, (unknown), (unknown), (unknown), (unknown), Dexing Zeng, Rui An, Xiaoli Lan, Yongkang Gai	0
3	¹⁷⁷Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy 2025 ·Journal of Medicinal Chemistry ·(unknown), Changyu Shan, (unknown), (unknown), Dexing Zeng, (unknown), Xiaoli Lan, Yongkang Gai	2
4	Development and evaluation of albumin binder-conjugated heterodimeric radiopharmaceuticals targeting integrin αvβ3 and CD13 for cancer therapy 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Changyu Shan, (unknown), (unknown), (unknown), Dexing Zeng, Rui An, Xiaoli Lan, Yongkang Gai	8
5	Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosis 2022 ·Journal of Translational Medicine ·Tao Liu, (unknown), Yi Yuan, Qunfang Yang, (unknown), Changyu Shan, (unknown), Hongwei Li, Xiang‐Qun Xie, Xiaohong Chen, Qin Ouyang	7
6	Simvastatin alleviated diabetes mellitus‐induced erectile dysfunction in rats by enhancing AMPK pathway‐induced autophagy 2020 ·Andrology ·Hang Fan, Changyu Shan, Hongwei Li, Yuping Zhang, Chunling Guo, Zhansong Zhou, Ji Zheng, Wenhao Shen, Qiang Dai, Qin Ouyang, Xiaojun Wu	23
7	CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification 2020 ·Molecular Cancer ·Mengmeng Jie, Yaran Wu, (unknown), Xinzhe Li, Cheng Liu, Qin Ouyang, (unknown), Changyu Shan, Yangfan Lv, Kebin Zhang, Qian Dai, Yang Chen, Shuo Zeng, Chenglin Li, Liting Wang, Fengtian He, C. Hu, Shiming Yang	137
8	Characterizing the Binding Sites for GK Domain of DLG1 and DLG4 via Molecular Dynamics Simulation 2020 ·Frontiers in Molecular Biosciences ·Hongwei Li, Qiong Chen, Changyu Shan, Chunling Guo, Xiuming Yang, Ying‐Chun Chen, Jinwei Zhu, Qin Ouyang	123
9	Discovery of Novel Autophagy Inhibitors and Their Sensitization Abilities for Vincristine‐Resistant Esophageal Cancer Cell Line Eca109/VCR 2020 ·ChemMedChem ·Changyu Shan, (unknown), Hongwei Li, Zheng Wang, Chunling Guo, (unknown), Jing Gu, Ying‐Chun Chen, Qin Ouyang	10
10	Binding interactions of epididymal protease inhibitor and semenogelin-1: a homology modeling, docking and molecular dynamics simulation study 2019 ·PeerJ ·Changyu Shan, Hongwei Li, Yuping Zhang, Yuyan Li, Ying‐Chun Chen, Wei He	8
11	2,3-Dicyano-5,6-dichlorobenzoquinone-Mediated and Selective C–O and C–C Cross-Couplings of Phenols and Porphyrins 2019 ·Organic Letters ·Qi Cheng, Zheng Wang, Hongwei Li, Changyu Shan, Peng‐Fei Zheng, Shuai Li, Yulong Li, Ying‐Chun Chen, Qin Ouyang	4
12	[4 + 1 + 1] Annulations of α-Bromo Carbonyls and 1-Azadienes toward Fused Benzoazaheterocycles 2019 ·Organic Letters ·Rong Zeng, Changyu Shan, Ming Liu, Kun Jiang, Ying Ye, Tianyu Liu, Ying‐Chun Chen	40
13	RhoA/ROCK/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo 2014 ·Cell Death and Disease ·Guobing� Li, (unknown), Changyu Shan, Qi Cheng, Amit Budhraja, Ting Zhou, Hongjuan Cui, Ning Gao	38
14	Mitochondrial translocation of cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/PI3K signaling pathway 2013 ·Cell Communication and Signaling ·Guobing� Li, Qi Cheng, Lei Liu, Ting Zhou, Changyu Shan, Xiaoye Hu, Jing Zhou, E‐Hu Liu, Ping Li, Ning Gao	52
15	Downregulation of Mcl-1 through inhibition of translation contributes to benzyl isothiocyanate-induced cell cycle arrest and apoptosis in human leukemia cells 2013 ·Cell Death and Disease ·Ting Zhou, Guobing� Li, Bo Cao, (unknown), Qi Cheng, Hui Kong, Changyu Shan, (unknown), Jing Chen, Ning Gao	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact